Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Oct;40(10):1834–1840. doi: 10.1172/JCI104407

THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER64 AND COPPER67*

Irmin Sternlieb 1,2, Anatol G Morell 1,2, Walter D Tucker 1,2, Margaret W Greene 1,2, I Herbert Scheinberg 1,2
PMCID: PMC290881  PMID: 16695870

Full text

PDF
1836

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENNHOLD H., KALLEE E. Comparative studies on the half-life of I 131-labeled albumins and nonradioactive human serum albumin in a case of analbuminemia. J Clin Invest. 1959 May;38(5):863–872. doi: 10.1172/JCI103868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DE VRIES A., ROSENBERG T., KOCHWA S., BOSS J. H. Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. Am J Med. 1961 Mar;30:486–494. doi: 10.1016/0002-9343(61)90057-2. [DOI] [PubMed] [Google Scholar]
  3. GERMAN J. L., 3rd, BEARN A. G. Effect of estrogens on copper metabolism in Wilson's disease. J Clin Invest. 1961 Mar;40:445–453. doi: 10.1172/JCI104272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GITLIN D., BORGES W. H. Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. Blood. 1953 Aug;8(8):679–686. [PubMed] [Google Scholar]
  5. HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
  6. MORELL A. G., SCHEINBERG I. H. Heterogeneity of human ceruloplasmin. Science. 1960 Mar 25;131(3404):930–932. doi: 10.1126/science.131.3404.930. [DOI] [PubMed] [Google Scholar]
  7. MORELL A. G., SCHEINBERG I. H. Preparation of an apoprotein from ceruloplasmin by reversible dissociation of copper. Science. 1958 Mar 14;127(3298):588–590. doi: 10.1126/science.127.3298.588-a. [DOI] [PubMed] [Google Scholar]
  8. RAYMUNT J., RUSS E. M. Influence of estrogens on total serum copper and caeruloplasmin. Proc Soc Exp Biol Med. 1956 Jul;92(3):465–466. doi: 10.3181/00379727-92-22512. [DOI] [PubMed] [Google Scholar]
  9. SCHEINBERG I. H., MORELL A. G. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. J Clin Invest. 1957 Aug;36(8):1193–1201. doi: 10.1172/JCI103515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SCHEINBERG I. H., STERNLIEB I. Copper metabolism. Pharmacol Rev. 1960 Sep;12:355–381. [PubMed] [Google Scholar]
  11. SCHEINBERG I. H., STERNLIEB I. Environmental treatment of a hereditary illness: Wilson's disease. Ann Intern Med. 1960 Dec 15;53:1151–1161. doi: 10.7326/0003-4819-53-6-1151. [DOI] [PubMed] [Google Scholar]
  12. Sternlier I., Morell A. G., Bauer C. D., Combes B., De Bobes-Sternberg S., Schein-Berg I. H. DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE. J Clin Invest. 1961 Apr;40(4):707–715. doi: 10.1172/JCI104304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. ZILVERSMIT D. B. The design and analysis of isotope experiments. Am J Med. 1960 Nov;29:832–848. doi: 10.1016/0002-9343(60)90117-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES